---
title: "Bombardier, Dividend 15, DRI Lead Scant Pack of Stocks at 52-Week Highs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292088996.md"
description: "Bombardier, Dividend 15, and DRI Healthcare Trust led a small group of stocks hitting 52-week highs. Bombardier showcased solutions at the Farnborough Airshow. Dividend 15 declared monthly distributions payable in July. DRI commented on FDA approval for Viridian's thyroid eye disease treatment. InterRent REIT completed its acquisition by Carriage Hill Properties. Nova Leap Health shareholders approved annual business items, while Savaria acquired Italian lift manufacturer Vipal S.p.A."
datetime: "2026-07-08T15:20:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292088996.md)
  - [en](https://longbridge.com/en/news/292088996.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292088996.md)
generator: "portal-rs"
---

# Bombardier, Dividend 15, DRI Lead Scant Pack of Stocks at 52-Week Highs

Bombardier Inc. (T.BBD-B) Hit a 52-Week High of $343.08. Bombardier Defense will have a strong presence at the Farnborough International Airshow on July-20-24, showcasing its proven solutions based on the top-performing Challenger and Global platforms.

Dividend 15 Split Corp. II (DF.TO) Hit a 52-Week High of $9.05. In mid-June, Dividend 15 Split Corp. II declares its monthly distribution of $0.10000 for each Class A share and $0.05833 for each Preferred share. Distributions are payable July 10, to shareholders on record as at June 30. 

DRI Healthcare Trust (T.DHT-UN) Hit a 52-Week High of $19.22. Early this month, DRI Healthcare Trust commented on Viridian Therapeutics, recently announced approval by the U.S. Food and Drug Administration of Lumvoa™ (veligrotug-vvze) for the treatment of thyroid eye disease. TED is an autoimmune inflammatory disorder of the orbit (eye socket) that affects numerous patients in the U.S. and can cause debilitating and disfiguring eye symptoms (e.g., inflammation, proptosis, and double-vision) with severe disease leading to vision loss.

InterRent Real Estate Investment Trust (T.IIP-UN) Hit a 52-Week High of $13.50. Last week, InterRent REIT announced that all closing conditions have been satisfied with respect to the previously announced plan of arrangement, pursuant to which Carriage Hill Properties Acquisition Corp. will acquire all of the units of the REIT (other than certain units of retained interest holders) for $13.55 per unit in cash by way of a statutory plan of arrangement under the provisions of the Business Corporations Act (Ontario).

Nova Leap Health Corp. (V.NLH) Hit a 52-Week High of 41 cents. In June, NOVA LEAP announced in mid-June that its shareholders voted in favour of all items of business brought before them at the Company’s annual and special meeting of shareholders held on June 10. 

Savaria Corporation (T.SIS) Hit a 52-Week High of $30.71. Last week, Savaria announced the acquisition of all issued and outstanding shares of  
Vipal S.p.A., a manufacturer of residential lifts and elevators based in Ferentillo, Italy.

### Related Stocks

- [VRDN.US](https://longbridge.com/en/quote/VRDN.US.md)

## Related News & Research

- [Viridian Therapeutics Chief Legal Officer Jennifer Tousignant disposes of common shares worth $348,194](https://longbridge.com/en/news/296547459.md)
- [12:25 ETRaymond Douglas, MD, PhD, Is First in the Nation to Infuse Newly FDA-Approved Thyroid Eye Disease Treatment, LUMVOA ™ (veligrotug-vvze)](https://longbridge.com/en/news/292931199.md)
- [Vitruvias Therapeutics, Inc. Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency](https://longbridge.com/en/news/296656249.md)
- [VRDN: FDA approves Lumvoa for TED, offering rapid, durable relief and broad patient access](https://longbridge.com/en/news/291165211.md)
- [Dri Healthcare Trust Delivers Record Earnings, Eyes Growth](https://longbridge.com/en/news/296009747.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**